Pursuant to Regulations 30, 33 and other applicable regulations of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Gujarat Inject Kerala has informed that the Board of Directors of the Company at its meeting held today Wednesday, 15th July, 2026 has discussed, approved, and taken on record the following matter: 1. Approved Un-Audited Financial Results of the Company for the First Quarter ended on 30th June, 2026; and 2. took on record ‘Limited Review Report’ thereon issued by S Mandawat & Co., Statutory Auditors of the Company. A copy of the approved Un-Audited Financial Results along with Limited Review Report are enclosed. The meeting commenced at 09:00 am and concluded at 09:45 am at the Registered Office of the Company.
The above information is a part of company’s filings submitted to BSE.
| Company Name | CMP |
|---|---|
| Sun Pharma. Inds. | 1941.00 |
| Dr. Reddys Labs. | 1152.60 |
| Cipla | 1410.90 |
| Lupin | 2369.45 |
| Zydus Lifesciences | 1108.90 |
| View more.. | |
Start Research-backed Investing ...Now. Subscribe to Sapphire
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: